Published in Women's Health Weekly, November 3rd, 2005
Study 1: Researchers compare the test performance of Inform HPV and hybrid capture 2 high-risk HPV DNA tests using the Surepath liquid-based Pap test as the collection method in a recent issue of the American Journal of Clinical Pathology.
"No U.S. Food and Drug Administration-approved method is available to test for human papillomavirus (HPV) DNA in the SurePath liquid-based Papanicolaou (Pap) test (TriPath Care Technologies, Burlington, NC). We compared the performance characteristics of Inform HPV (Ventana Medical Systems, Tucson, AZ) and Hybrid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly